India is experiencing a spike in Covid-19 cases, with the highest number reported in Kerala, and concerns are rising about the JN.1 sub-variant. The country has witnessed an upward trend in active cases, reaching 4,054 patients. Despite the increasing prevalence of the JN.1 sub-variant, health authorities, including former AIIMS director Dr Randeep Guleria, assure that it is not causing severe infections or hospitalizations.
Dr NK Arora, chief of the India SARS-CoV-2 Genomics Consortium (INSACOG), stated that an additional vaccine dose is currently not necessary specifically for the JN.1 sub-variant. However, health experts recommend precautionary booster doses to enhance protection against various sub-variants and virus mutations.
While the World Health Organization (WHO) has classified JN.1 as a variant of interest, it emphasizes that the overall risk remains low based on current evidence. The WHO has urged Southeast Asian countries, including India, to intensify surveillance and implement protective measures.
As the situation unfolds, health authorities continue to monitor and adapt precautionary measures to curb the spread of the virus and mitigate the impact of emerging sub-variants.
The privately funded mission, named Fram2, was commissioned by Maltese-Chinese billionaire Chun Wang and aimed…
According to the State of Forests Report, Telangana’s forests occupy about 24% of the state's…
Cavit Çetin Günîr, who portrays the fierce warrior Doğan Bey in the popular Turkish show…
Jain faces multiple criminal charges including extortion, illegal arms possession, kidnapping, and supplying contraband to…
The video Trump reposted includes several dubious claims. Among them is the assertion that billionaire…
According to the complaint, Rahul Gandhi intentionally made false and damaging accusations against Savarkar to…
